Nautilus Biotechnology, Inc.
NAUT
$2.51
$0.041.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.31% | -12.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.31% | -9.50% | |||
| Operating Income | 0.31% | 9.50% | |||
| Income Before Tax | -1.52% | 9.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.52% | 9.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.52% | 9.71% | |||
| EBIT | 0.31% | 9.50% | |||
| EBITDA | 0.18% | 9.58% | |||
| EPS Basic | -2.33% | 9.74% | |||
| Normalized Basic EPS | -3.27% | 9.68% | |||
| EPS Diluted | -2.33% | 9.74% | |||
| Normalized Diluted EPS | -3.27% | 9.68% | |||
| Average Basic Shares Outstanding | -0.81% | 0.08% | |||
| Average Diluted Shares Outstanding | -0.81% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||